MINT, UNIV Angers, SFR-ICAT, INSERM U1066, CNRS 6021, Angers 4208, France; CHU Angers, Angers 49033, France.
MINT, UNIV Angers, SFR-ICAT, INSERM U1066, CNRS 6021, Angers 4208, France.
Eur J Pharm Sci. 2023 Oct 1;189:106537. doi: 10.1016/j.ejps.2023.106537. Epub 2023 Jul 23.
The parameters currently used for characterization of nanoparticles, such as size and zeta potential, were not able to reflect the performance of a nanocarrier in the biological environment. Therefore, more thorough in vitro characterization is required to predict their behavior in vivo, where nanoparticles acquire a new biological identity due to interactions with biomolecules. In this present study, we performed in vitro characterization in biological fluids for lipid nanocapsules (LNCs) with varying means sizes (50 nm and 100 nm), different electrical surface charges and different Poly Ethylene Glycol (PEG) compositions. Then, different methods were applied to show the impact of the protein corona formation on LNCs. Even if all formulations attached to plasmatic proteins, a higher thickness of corona and highest protein binding was observed for certain LNC50 formulations. A better knowledge of the phenomenon of protein adsorption over NPs in the plasmatic media is a cornerstone of clinical translation. In fact, after short blood circulation time, it is not the initially designed nanoparticle but the complex nanoparticle bearing its protein corona which circulates to reach its target.
目前用于纳米颗粒特性描述的参数,如大小和zeta 电位,无法反映纳米载体在生物环境中的性能。因此,需要更彻底的体外特性描述来预测它们在体内的行为,因为纳米颗粒与生物分子相互作用后会获得新的生物学特性。在本研究中,我们在具有不同平均粒径(50nm 和 100nm)、不同表面电荷和不同聚乙二醇(PEG)组成的脂质纳米囊(LNC)的生物流体中进行了体外特性描述。然后,应用不同的方法来表明蛋白质冠形成对 LNC 的影响。尽管所有制剂都与血浆蛋白结合,但对于某些 LNC50 制剂,观察到了更高的冠厚度和最高的蛋白结合。更好地了解 NPs 在血浆介质中吸附蛋白质的现象是临床转化的基石。事实上,在短暂的血液循环时间后,循环到靶部位的不是最初设计的纳米颗粒,而是携带其蛋白质冠的复杂纳米颗粒。